Tristan Rousselle


Aryballe Technologies

Tristan is the CEO of Aryballe Technologies.

Tristan earned his Cellular and Molecular Biology PdD at University Grenoble Alpes in 1999. He then co-founded PX Therapeutics, a biotechnology company, where he held the CEO position until its acquisition by Laboratoire Aguettant in 2012. In 2014 together with a group of entrepreneurs and Technologists he co-founded Aryballe Technology, a start-up specialized the development and commercialisation of Artificial Noses for Industrial and consumer applications